Join Cromos Pharma’s Vlad Bogin at OCT Eastern Europe June 15 Why are Central and Eastern Europe the hottest locations for clinical trials? Join Vlad Bogin, MD, FACP, CEO Cromos Pharma at #OCTEasternEurope15 June 2021 to find out more. At Cromos Pharma we have in-depth knowledge of these regions and the expertise to manage your clinical trial from start to end. Email bd@cromospharma.com to set up a meeting to discuss your needs.
EU drug and device legislation: What you need to know After a year-long delay due to the COVID-19 pandemic, the EU Medical Devices Regulation (EU MDR) is set to come into effect on May 26th 2021. Regulation 2017/746 on In-Vitro Diagnostic Devices (IVDR) will come into effect May 2022 after a five year transition period. These Regulations have a staggered transitional period with some aspects becoming legally binding after 6 months of
Reasons why Georgia needs to be on your list of locations for clinical trials With its rapid regulatory approval process, significant naïve populations in a range of therapeutic areas, skilled medical personnel and a conducive economic environment for doing business, Georgia is regarded as a hidden gem for those interested in initiating novel studies and rescue trials. Cromos Pharma in Georgia Cromos Pharma began managing clinical research in Georgia
